SKU
565207
FlowFlex Covid-19 Antigen Home Test, 300/Carton
$7.07
Flowflex COVID-19 Home Test, FDA authorized Antigen test that requires only 1 test, results in 15 minutes, Nasal Swab. A rapid test for the detection of SARS-CoV-2 antigens in anterior nasal specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19 infection.
Please allow 7-10 business days for delivery.
1. Anterior nasal swab specimens
2. Results in 15 minutes
3. 12 Months shelf life
4. Store between 36 to 86° F
5. Sample self-collection ages 14 and older
6. Sample collection by an adult in children ages 2 to 13
7. Excellent performance when compared to an FDA authorized molecular SARS-CoV-2 test.
8. One carton contains 300 tests.
Warnings
This product has not been FDA cleared or approved but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
2. Results in 15 minutes
3. 12 Months shelf life
4. Store between 36 to 86° F
5. Sample self-collection ages 14 and older
6. Sample collection by an adult in children ages 2 to 13
7. Excellent performance when compared to an FDA authorized molecular SARS-CoV-2 test.
8. One carton contains 300 tests.
Warnings
This product has not been FDA cleared or approved but has been authorized by FDA under an EUA. This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.
Need to Place a Large Volume Order? Connect With Our Team.
Call us
Send us an email
Fill out our contact form
We will respond to you within 1 business day!